Filippo Crea
doi : 10.1093/eurheartj/ehac381
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2715–2719
Thomas Münzel
doi : 10.1093/eurheartj/ehac225
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2720–2721
Mohammed Y Khanji, Shabaz Ahmad, Imran Zaman, Fabrizio Ricci
doi : 10.1093/eurheartj/ehac232
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2722–2724
Emma Luisa Hempstead
doi : 10.1093/eurheartj/ehac269
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2725–2726
Leonarda Galiuto, Carlo Patrono
doi : 10.1093/eurheartj/ehac314
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2727–2728
Stephan Windecker, Taishi Okuno, Axel Unbehaun, Michael Mack, Samir Kapadia, Volkmar Falk
doi : 10.1093/eurheartj/ehac105
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2729–2750
Transcatheter aortic valve implantation (TAVI) has matured into a standard treatment option for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of risk. The advances in the interventional treatment of AS raise the question of which patients with severe AS should be referred to surgery.
Holger Thiele, Jean Philippe Collet, Martin Leon, Roxana Mehran
doi : 10.1093/eurheartj/ehac131
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2751–2752
Victor Dayan, Walter J Gomes
doi : 10.1093/eurheartj/ehac154
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2753–2755
Christophe Tribouilloy, Yohann Bohbot, Maciej Kubala, Frank Ruschitzka, Bogdan Popescu, Olaf Wendler, Cécile Laroche, Elektra Bartha, Huseyin Ince, Iveta Simkova, Alec Vahanian, Bernard Iung
doi : 10.1093/eurheartj/ehac209
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2756–2766
To assess the characteristics, management, and survival of patients with multiple native valvular heart disease (VHD).
Rebecca T Hahn, Philippe Pibarot, Catherine M Otto
doi : 10.1093/eurheartj/ehac229
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2767–2769,
William K F Kong, Antonio Salsano, Daniele Roberto Giacobbe, Bogdan A Popescu, Cécile Laroche, Xavier Duval, Robert Schueler, Antonella Moreo, Paolo Colonna, Cornelia Piper, Francisco Calvo-Iglesias, Luigi P Badano, Ilija Srdanovic, David Boutoille, Olivier Huttin, Elisabeth Stöhr, Ana Teresa Timóteo, Jolanta Justina Vaskelyte, Anita Sadeghpour, Pilar Tornos, Leila Abid, Kian Keong Poh, Gilbert Habib, Patrizio Lancellotti
doi : 10.1093/eurheartj/ehac307
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2770–2780
Fatality of infective endocarditis (IE) is high worldwide, and its diagnosis remains a challenge. The objective of the present study was to compare the clinical characteristics and outcomes of patients with culture-positive (CPIE) vs. culture-negative IE (CNIE).
Emil L Fosbøl
doi : 10.1093/eurheartj/ehac230
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2781–2782
Jean Philippe Collet, Eric Van Belle, Holger Thiele, Sergio Berti, Thibault Lhermusier, Thibault Manigold, Franz Josef Neumann, Martine Gilard, David Attias, Farzin Beygui, Angel Cequier, Fernando Alfonso, Pierre Aubry, Flore Baronnet, Stéphane Ederhy, Mohamad El Kasty, Mathieu Kerneis, Olivier Barthelemy, Thierry Lefèvre, Pascal Leprince, Alban Redheuil, Patrick Henry, Jean Jacques Portal, Eric Vicaut, Gilles Montalescot, for the ATLANTIS Investigators of the ACTION Group
doi : 10.1093/eurheartj/ehac242
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2783–2797
The respective roles of oral anticoagulation or antiplatelet therapy following transcatheter aortic valve implantation (TAVI) remain debated. ATLANTIS is an international, randomized, open-label, superiority trial comparing apixaban to the standard of care.
Felicita Andreotti, Massimo Massetti, Jurrien ten Berg
doi : 10.1093/eurheartj/ehac139
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2798–2800
Gijs J van Steenbergen, Queeny H Y Tsang, Olivier W.H. van der Heijden, Priya Vart, Laura Rodwell, Jolien W Roos-Hesselink, Roland R J van Kimmenade, Wilson W L Li, Ad F T M Verhagen
doi : 10.1093/eurheartj/ehac234
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2801–2811
To investigate the association between the timing of cardiac surgery during pregnancy and both maternal and foetal outcomes.
Aditya C Shekhar
doi : 10.1093/eurheartj/ehac279
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2812–2813
Linn Andelius, Fredrik Folke, Carolina Malta Hansen
doi : 10.1093/eurheartj/ehac300
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Pages 2814–2815,
Aljona Friedrich, Miralem Pasic, Volkmar Falk
doi : 10.1093/eurheartj/ehac195
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Page 2816
doi : 10.1093/eurheartj/ehac341
European Heart Journal, Volume 43, Issue 29, 1 August 2022, Page 2813
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟